The latest innovations in ophthalmic care for glaucoma patients

Ora Chief Medical Officer Gustavo De Moraes, MD, PhD, MPH, speak with Ophthalmology Times®' Sheryl Stevenson to discuss some of the cutting-edge advancements in therapies and diagnostics for the treatment of glaucoma patients.

Related Videos

Related Content

Advertisement

October 11th 2024

Key lectures and awards at the AAO 2024 meeting

September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

October 9th 2024

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Published: October 9th 2024 | Updated: October 9th 2024

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting

October 9th 2024

Clearside Biomedical unveils positive topline results from ODYSSEY Phase 2b Trial of suprachoroidal CLS-AX in wet AMD

Related Content

Advertisement

October 11th 2024

Key lectures and awards at the AAO 2024 meeting

September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

October 9th 2024

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Published: October 9th 2024 | Updated: October 9th 2024

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting

October 9th 2024

Clearside Biomedical unveils positive topline results from ODYSSEY Phase 2b Trial of suprachoroidal CLS-AX in wet AMD